Evidence map›Paper›PMID 19656913›Full record

ReviewAmerican journal of physiology. Renal physiology2010

Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium.

David Sheikh-Hamad

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Renal physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Identification ofBiomedicines · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

David Sheikh-HamadDivision of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. sheikh@bcm.tmc.edu
Baylor College of Medicine · US

Funding

Renal Inflammation: Mechanisms and ConsequencesP50DK064233 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MITCH, WILLIAM EVANS · 2003 to 2007
$5.1M
Stanniocalcin-1, a novel anti-inflammatory proteinR01DK080306 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI SHEIKH-HAMAD, DAVID · 2009 to 2013
$1.7M
SMAD SIGNALING IN ANGIOTENSIN II-MEDIATED RENAL FIBROSISR01DK062828 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MITCH, WILLIAM EVANS · 2005 to 2006
$680k
NIDDK NIH HHS DK-062828NIDDK NIH HHS DK-080306NIDDK NIH HHS DK-62703-04NIDDK NIH HHS P50 DK064233NIDDK NIH HHS P50-DK-64233-01NIDDK NIH HHS R01 DK080306
6 · The paper itself

Abstract

The mammalian homolog of the fish calcium regulatory hormone stanniocalcin-1 (STC1) is ubiquitously expressed and likely functions in an autocrine/paracrine fashion. Mammalian STC1 does not appear to exert significant effects on serum calcium, and its physiological role remains to be determined. In macrophages, STC1 decreases intracellular calcium and cell mobility; attenuates the response to chemoattractants; and diminishes superoxide generation through induction of uncoupling protein-2 (UCP2). In cytokine-treated endothelial cells, STC1 attenuates superoxide generation and the activation of inflammatory pathways [c-Jun NH(2)-terminal kinase (JNK) and NF-kappaB]; maintains the expression of tight junction proteins, preserving the endothelial monolayer seal; and decreases transendothelial migration of leukocytes. Combined, the effects of STC1 on endothelial cells and macrophages predict potent anti-inflammatory action. Indeed, application of the anti-glomerular basement membrane (GBM) glomerulonephritis model to STC1 transgenic mice that display increased expression of STC1 transgene in endothelial cells and macrophages yields renal protection. Our data suggest that STC1 activates antioxidant pathways in endothelial cells and macrophages and displays cytoprotective and anti-inflammatory actions.

Indexed as

CytoprotectionAnimalsAnti-Glomerular Basement Membrane DiseaseAnti-Inflammatory AgentsAntioxidantsCytokinesEndotheliumGlomerulonephritisGlycoproteinsHumansIon ChannelsMacrophagesMitochondrial ProteinsPermeabilityProtein IsoformsReceptors, Cell SurfaceAnti-Inflammatory AgentsAntioxidantsCytokinesGlycoproteinsIon ChannelsMitochondrial ProteinsProtein IsoformsReceptors, Cell SurfaceSuperoxidesteleocalcinUncoupling Protein 1

Identifiers

PMID19656913
PMCPMC3774476
OpenAlexW2140714811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.